NCT02605395View on ClinicalTrials.gov

Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 22, 2014

Primary Completion Date

March 30, 2014

Study Completion Date

March 30, 2014

Conditions
Gastrointestinal Diseases
Interventions
DRUG

IDIAZOLE 20mg DR tabs

IDIAZOLE 20mg DR tabs is a delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium.

DRUG

PARIET 20 mg DR tabs

PARIET 20 mg DR tabs is a delayed-release, enteric-coated tablets containing 20 mg rabeprazole sodium.

Trial Locations (1)

Unknown

GSK Investigational Site, Cairo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY